| file | CiteScore | SJR | IF | Journal | Authors | Title | ||||
![]() |
Scopus | 9.7 Q1 |
1.225 Q1 |
4.8 Q1 |
|
Alireza Sharafshah,Parvaneh Keshavarz, et al. |
A GWAS Meta-meta-analysis and In-depth Silico Pharmacogenomic Investigations in Identification of APOE and Other Genes Associated with Pain, Anti-inflammatory, and Immunomodulating Agents in Opioid Use Disorder (OUD) Derived from 14.91 M Subjects Original Article |
|||
![]() |
Scopus | 4 Q2 |
0.642 Q2 |
2 Q3 |
35(1):- |
Masoumeh Faghani, et al. |
|
|||
| file | Scopus | 3.6 Q3 |
0.428 Q3 |
1.3 Q4 |
Journal of Pharmacological and Toxicological Methods 131: 107571 |
Behrouz Golichenari,et al. | Compromising the immunogenicity of diphtheria toxin-based immunotoxins through epitope engineering: An in silico approach Original Article |
|||
![]() |
Scopus | 2.6 Q3 |
0.39 Q3 |
1.3 |
|
Shabnam Vahdani, et al |
Original Article
|
|||
![]() |
Scopus | 6.7 Q1 |
0.874 Q1 |
3.9 Q1 |
15(1):- |
Nasrin Ghanami Gashti, et al |
|
|||
| file | Scopus | 3.8 Q2 |
0.534 Q3 |
1.6 |
|
Saima Abbaspour, Parvaneh Keshavarz, et al |
|
|||
![]() |
Scopus | 5.6 Q1 |
1.008 Q2 |
2.8 Q3 |
589:33-49 |
Candice Yu, et al. |
Exercise-driven modulation of glutamatergic signaling: mechanisms and clinical implications Review |
|||
![]() |
Scopus | 7.9 Q1 |
0.911 Q1 |
2.4 Q2 |
|
Sara Sareminejad, Shirzad Fallahi, et al. |
|
|||
|
Scopus |
5.4 |
0.803 Q1 |
2.6 Q2 |
|
Parisa Afzal Haghjoo, Malek Moien Ansar, Malek Masoud Ansar, et al. |
|
|||